CCD 3045
Latest Information Update: 17 Jan 1995
Price :
$50 *
At a glance
- Originator Purdue Pharma
- Class Anxiolytics; Hypnosedatives; Sleep disorder therapies
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 30 Dec 1994 Discontinued-I for Anxiety disorders in United Kingdom (Unknown route)